Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension

Background Women with chronic hypertension are at increased risk for adverse maternal and perinatal outcomes. Maternal serum angiogenic markers, such as soluble fms-like tyrosine kinase 1 and placental growth factor, can be used to triage women with suspected preeclampsia. However, data about these markers in pregnant women with chronic hypertension are scarce. Objective We aimed to evaluate the predictive accuracy of maternal serum levels of...